
Opentrons
Founded Year
2014Stage
Series C | AliveTotal Raised
$250.83MValuation
$0000Last Raised
$200M | 4 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-39 points in the past 30 days
About Opentrons
Opentrons operates as a life science company automating laboratory processes with its integrated laboratory platform. The company provides liquid handling laboratory robots and cell engineering solutions for research and healthcare. Opentrons serves academic, biopharma, synthetic biology, and clinical research sectors. It was founded in 2014 and is based in Long Island City, New York.
Loading...
Loading...
Expert Collections containing Opentrons
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Opentrons is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,309 items
Robotics
2,753 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Game Changers 2018
70 items
Artificial Intelligence (AI)
20,629 items
Opentrons Patents
Opentrons has filed 13 patents.
The 3 most popular patent topics include:
- molecular biology
- laboratory equipment
- biotechnology

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/24/2022 | 10/1/2024 | Laboratory equipment, Laboratory glassware, Electrophysiology, Volumetric instruments, Neurophysiology | Grant |
Application Date | 10/24/2022 |
|---|---|
Grant Date | 10/1/2024 |
Title | |
Related Topics | Laboratory equipment, Laboratory glassware, Electrophysiology, Volumetric instruments, Neurophysiology |
Status | Grant |
Latest Opentrons News
Oct 30, 2025
Written By: Copied Every industry needs effective and ethical leadership, for reasons both moral and practical. A leader who makes effective decisions, treats their team with respect, and operates with integrity in accordance with a well-defined set of core values is a leader who is able to guide a company through struggles and come out stronger both individually and as a team. This is especially true in the healthcare sector, where companies and organizations are working with patients’ physical and mental well-being, and their personal information. A leader who fails to keep sharp, leads without integrity, and makes poor decisions is a leader who not only fails their team, but opens their company up to litigation and entirely avoidable trouble. understands the importance of ethical leadership. His experience spans national clinical laboratories, health systems, and diagnostic services, and he’s led businesses through transformations, P&L growth, complex mergers and acquisitions, and product innovation. With his recent roles including Vice President and General Manager of the Pandemic Response Laboratory at Opentrons, and prior president-level roles within Eurofins Clinical Diagnostics, has established himself as a leader who builds high-performance teams, fosters accountability, and delivers outcomes-driven solutions wherever possible. Mitilenes could not have achieved this level of success and become the leader that he is today without developing his skills, building strong and lasting relationships with mentors, and tailoring his career to grow in alignment with his values. All together, his experiences represent a constellation of choices that form a pattern he thinks can be passed on to future leaders, and he’s eager to share the wisdom he’s gained through firsthand experience. “To me, success as a leader isn’t measured in one day, quarter, or year; success is the sustainable creation of economic and moral value,” Nickolas Mitilenes explains. “In this way, you not only create momentum that is in line with your and your organization’s values, but inspire those around you to do the same long after your time as a leader has concluded.” Seek Challenges to Find Self-Improvement Nick Mitilenes grew up around clinical laboratory diagnostics; his grandfather founded a laboratory in 1951, and the family has been in the business ever since. While those early inspirations—both in healthcare and in business—were major influences in Mitilenes’ career decisions, his aptitude for leadership and his vision for growth came naturally. He was drawn to the idea of serving many patients at once, rather than one at a time, and saw best-in-class technology, data analytics, and robust processes as his vehicle for doing so. “After growing up seeing my family manage a community-based lab, with all its trials and tribulations, I felt compelled to bring in fresh ideas, which, at that time, was the power of molecular diagnostics for infectious disease testing,” says Mitilenes. It was a direction that wasn’t without its challenges, but challenges are opportunities for learning, growth, and new development. It’s the one piece of advice Nickolas Mitilenes wishes he could give his younger self: to seek challenge as much as possible, whether that’s surrounding himself with more successful peers or taking on a role with prerequisites that are somewhat beyond him. It’s advice he gives to others who look to him for mentorship; embracing challenging roles and circumstances gives a young professional the diversity of experience they’ll need to solve problems and innovate. “Challenges sought out in a healthy manner make us more productive in the near and long term; diversity of experience makes us think about the same thing in new and unexpected ways,” says Mitilenes. “By pushing the limits of our capabilities and comfort, significant self-improvement can be achieved as well as inspire others around you to do the same.” For a leader and professional to find success, they need to be seeking out new opportunities to learn and grow—otherwise they’ll just be left behind. This means putting in the work, even outside of exciting new challenges; reading industry publications, attending conferences, building a strong professional network, and otherwise maintaining a robust and up-to-date knowledge base is essential. Stay Grounded and Act Decisively It’s incredibly important for leaders to avoid knee-jerk reactions and underinformed decisions, but those are precisely the kinds of responses many people leap to when times get tough and the stakes are high. Unfortunately, those responses most commonly only make the situation worse. “Instead, I stay focused on overarching goals and areas of responsibility, aiming for a balance of speed and thoughtfulness that advances progress without bypassing team consensus,” Mitilenes explains. “Once a decision is made, I believe in maintaining momentum while remaining open to new, material information that may warrant adaptation.” It’s these moments of tension that define someone’s leadership capability, in large part also because they test their integrity as an individual. It’s easy to hold to values and vision when everything is smooth sailing, but it’s just as easy to abandon them in stormy waters. Nickolas Mitilenes has experienced this firsthand on many occasions; for him, these instances often had him choosing between the insufficient (but easier) status quo and/or stakeholder expectations, and the regulation-compliant and correct (but harder) alternative route. “For instance, I once had to pull a lab test from the market because I believed clinical performance was not appropriate for the intended audience, even though analytical performance was acceptable,” he recalls. “This was damaging financially as well as for staff morale; however, it was ultimately in the best interests of our patients, clients, and our organization in the long term.” Being a leader worth following requires integrity and a grounded position in one’s own values, the company's goal, and the team’s vision, and there is no better time to prove it than during times of hardship. Staying grounded has another benefit, and it’s the gift of mental clarity, even in high-stakes positions. “When trying to meet operational, financial, or quality goals, it is easy to get lost in the details and stray from balance and clarity of thought,” says Mitilenes. “By remembering that patients are the North Star, and that decisions should be made that put them first as well as enable the organization to best serve them now and in the future, you can often push away distractors and focus on what will truly drive the best outcomes.”
Opentrons Frequently Asked Questions (FAQ)
When was Opentrons founded?
Opentrons was founded in 2014.
Where is Opentrons's headquarters?
Opentrons's headquarters is located at 45-18 Court Square West, Long Island City.
What is Opentrons's latest funding round?
Opentrons's latest funding round is Series C.
How much did Opentrons raise?
Opentrons raised a total of $250.83M.
Who are the investors of Opentrons?
Investors of Opentrons include Khosla Ventures, SoftBank, SOSV, Lerer Hippeau, Y Combinator and 19 more.
Who are Opentrons's competitors?
Competitors of Opentrons include CyRISBio and 7 more.
Loading...
Compare Opentrons to Competitors

Quartzy is a cloud-based platform for laboratory management within the life sciences sector. The company offers services that manage lab communications, inventory, and the procurement of lab supplies. Quartzy primarily serves the life sciences industry, providing tools for operational tasks related to scientific research. It was founded in 2009 and is based in Hayward, California.

Opvia is a company focused on providing lab software solutions for the biotechnology R&D sector. Their main offerings include a cloud-based platform for structured experimental data, analytics, and lab management, designed to streamline workflows and enhance data accessibility. The company primarily serves the biotechnology research and development industry, offering tools for quality management, data monitoring, and compliance. It was founded in 2019 and is based in London, England.

Strateos operates within the life sciences sector, specializing in cloud-based laboratory automation and control. The company offers a platform that allows scientists to design, execute, and analyze experiments remotely, utilizing high-throughput robotics and automation. Strateos serves sectors such as pharmaceuticals, biotechnology, academic research, and contract research organizations. Strateos was formerly known as Transcriptic. It was founded in 2012 and is based in Menlo Park, California.

Uncountable operates as a cloud-based platform that provides tools for research and development workflows within the scientific and manufacturing sectors. The company offers electronic lab notebooks, laboratory information management systems, and data visualization and predictive analytics to support research and development (R&D) processes. Uncountable serves industries such as chemicals, pharmaceuticals, biotechnology, advanced materials, and food and agriculture. It was founded in 2016 and is based in San Francisco, California.
Let's Go Robotics specializes in laboratory automation within the LifeSciences sector. The company offers a range of products including precision dispensers, grippers, and automation platforms designed to enhance lab efficiency and accuracy. These products serve the needs of various sectors within the LifeSciences industry, such as pharmaceuticals, biotechnology, and research institutions. It is based in Carlsbad, California.

Labguru is a lab management software platform that specializes in streamlining laboratory operations and data management for the life sciences sector. It offers an integrated suite of tools, including an electronic lab notebook (ELN), a laboratory information management system (LIMS), and inventory management, designed to enhance research efficiency and collaboration. Labguru's platform is tailored to meet the needs of various sectors within the life sciences industry, such as biotech, pharma, food tech, and quality control labs. It was founded in 2008 and is based in Westborough, Massachusetts.
Loading...